ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 359 out of 1677

$650K Total Retail Price of All Prescriptions

Rank: 213 out of 1677

403 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
METOPROLOL SUCCINATE 291 212 1 23
LEVOTHYROXINE SODIUM 278 209 2 5
LISINOPRIL 265 201 3 3
TRAMADOL HCL 252 160 4 16
GABAPENTIN 223 105 5 11
ZOLPIDEM TARTRATE 215 141 6 15
AMLODIPINE BESYLATE 213 150 7 2
NEXIUM 201 135 8 19
SIMVASTATIN 199 172 9 1
PRAVASTATIN SODIUM 193 155 10 10
OMEPRAZOLE 190 126 11 6
GLIMEPIRIDE 163 130 12 33
FLUTICASONE PROPIONATE 152 101 13 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 114 14 17
CITALOPRAM HBR 142 109 15 22
LEVOFLOXACIN 140 82 16 84
AMOXICILLIN 139 77 17 94
FUROSEMIDE 133 86 18 8
FENOFIBRATE 130 97 19 48
WARFARIN SODIUM 127 111 20 24
HYDROCODONE-ACETAMINOPHEN 119 77 S3 21 4
ALLOPURINOL 119 84 21 31
METFORMIN HCL 117 76 23 7
LOSARTAN POTASSIUM 114 84 24 25
ATORVASTATIN CALCIUM 105 67 25 13
ATENOLOL 101 80 26 21
POTASSIUM CHLORIDE 95 58 27 14
PREDNISONE 94 48 28 40
KLOR-CON 10 91 41 29 106
HYDROCHLOROTHIAZIDE 88 53 30 9
FAMOTIDINE 86 68 31 41
AMOX TR-POTASSIUM CLAVULANATE 82 57 32 126
NAMENDA 82 76 32 39
TRIAMTERENE-HCTZ 82 56 32 61
CARVEDILOL 81 72 35 20
BUSPIRONE HCL 78 53 36 120
MELOXICAM 78 46 36 27
ADVAIR DISKUS 77 55 38 54
ALENDRONATE SODIUM 75 64 39 43
DIOVAN HCT 74 62 40 66
NIASPAN 74 62 40 128
DONEPEZIL HCL 73 73 42 30
METOPROLOL TARTRATE 73 41 42 12
CIPROFLOXACIN HCL 73 43 42 57
SERTRALINE HCL 68 42 45 26
LUNESTA 66 23 46 260
CYMBALTA 61 34 47 58
TRAZODONE HCL 61 26 47 37
LOSARTAN-HYDROCHLOROTHIAZIDE 56 43 49 42
CLOPIDOGREL 54 53 50 32
LOVAZA 54 39 50 201
TIZANIDINE HCL 54 16 50 108
INSULIN SYRINGE 54 39 50 72
FLUCONAZOLE 52 29 54 127
LEVEMIR FLEXPEN 52 27 54 207
CELEBREX 51 41 56 102
SPIRIVA 51 20 56 74
CLONIDINE HCL 50 45 58 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.